1441.0000 -29.90 (-2.03%)
NSE Nov 21, 2025 15:31 PM
Volume: 36,736
 

1441.00
-2.03%
Prabhudas Lilladhar
JLHL's Q1 consolidated EBITDA grew by 20% YoY (flat QoQ) to Rs781mn, in line with our estimates, aided by higher ARPOB. Its operational efficiency has been strong in the competitive markets of MMR. The company reported revenue/EBITDA CAGR of 20%/25% over FY22-25. Given its expansion plans, scale-up in occupancy and improving margins, growth momentum is expected to sustain over the medium term. We believe strategic greenfield expansions in densely populated micro-markets of western regions will drive sustainable...
Prabhudas Lilladhar increased Buy price target of Jupiter Life Line Hospitals Ltd. to 1800.0 on 11 Nov, 2025.
More from Jupiter Life Line Hospitals Ltd.
Recommended